๐ฆ๐ฒ๐ฝ๐๐ฒ๐บ๐ฏ๐ฒ๐ฟ ๐ถ๐ ๐ข๐๐ฎ๐ฟ๐ถ๐ฎ๐ป ๐๐ฎ๐ป๐ฐ๐ฒ๐ฟ ๐๐๐ฎ๐ฟ๐ฒ๐ป๐ฒ๐๐ ๐ ๐ผ๐ป๐๐ต โ a time to raise awareness, support research, and share life-saving information. Ovarian cancer affects about 300,000 women worldwide each year and is the deadliest of the major gynecologic cancers. Early detection saves lives: 5-year survival is ~95% when found early but drops to ~20% for stage III/IV. Because symptoms are often vague (bloating, early satiety, pelvic or lower back pain, urinary changes), paying attention to persistent or unusual changes and seeing a clinician can make all the difference.
๐๐ผ๐ ๐ถ๐บ๐บ๐๐ป๐ผ๐๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ ๐ถ๐ ๐ต๐ฒ๐น๐ฝ๐ถ๐ป๐ด ๐ฎ๐ป๐ฑ ๐๐ต๐ ๐ถ๐ ๐บ๐ฎ๐๐๐ฒ๐ฟ๐
- Tumor-infiltrating T cells are linked to better survival โ immune response matters.
- Checkpoint inhibitors have shown limited benefit so far in many ovarian cancers, likely because high genomic instability lets tumors adapt and resist immune attack.
- Promising approaches in trials include antibody-drug conjugates (ADCs) that deliver targeted chemotherapy directly to cancer cells.
- Researchers are developing new biomarkers (for example, studying mucin glycosylation) to detect ovarian cancer earlier and more accurately.
๐ช๐ต๐ฎ๐ ๐๐ผ๐ ๐ฐ๐ฎ๐ป ๐ฑ๐ผ
- Know the symptoms and act: persistent bloating, early fullness, pelvic/abdominal/back pain, changed bathroom habits โ discuss them with your provider.
- Support clinical trials and research โ new immunotherapies and biomarkers depend on participation and funding.
- Share this message to increase awareness during Ovarian Cancer Awareness Month.
If you or someone you love has risk factors or persistent symptoms, contact a healthcare provider for evaluation โ early action saves lives.
#OvarianCancerAwareness #OvarianCancer #Immunotherapy #CancerResearch #EarlyDetection #WomenHealth #ClinicalTrials #ADC #Biomarkers #GynOncology #KnowTheSymptoms #Survivorship #ResearchMatters #HealthAwareness #SCABPharmacy